May 2nd 2024
Study reveals concerning trends from the mosquito-borne disease impacting Canada and the US.
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
Understanding RSV: What You Need to Know to Prevent and Treat Respiratory Syncytial Virus in Your Patients
View More
Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines
View More
(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?
View More
Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)
View More
Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care
View More
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes
View More
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer
View More
Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients
View More
Overcoming Racial Disparities in Multiple Myeloma Outcomes and Clinical Trials: How We are Moving Care Forward Today
View More
SIGA Technologies, Inc Submits NDA for First-Ever Oral Smallpox Treatment
December 12th 2017Although deemed eradicated throughout the world in 1980 thanks to a protective vaccine, research on smallpox continues to this day given the potential for the highly contagious virus to be used in biological warfare.
Read More
Advances Are Being Made in Diagnostic Testing for Early Lyme Disease
December 7th 2017Experts from academia, industry, and public health agencies—including the Centers for Disease Control and Prevention and the US Food and Drug Administration—discuss the new generation of antibody tests.
Read More
New POC Test for Zika Virus Awarded Conditional LTA from UNICEF
November 28th 2017Chembio Diagnostics, Inc.’s DPP Zika System, was recently awarded a conditional Long-Term Arrangement (LTA) for purchasing from the United Nations Children's Fund (UNICEF), once the company satisfies certain conditions.
Read More